PDSB logo

PDS Biotechnology (PDSB) Cash From Operations

Annual CFO

-$33.64 M
-$7.93 M-30.83%

December 31, 2023

Summary

Performance

1-Year Change

-30.83%

3-Year Change

-155.81%

5-Year Change

-1.46%

15-Year Change

+17.35%

PDSB Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.67%
PDSB annual cash flow from operations is higher than 35.67% of companies in Healthcare sector

High & Low

All-time High

-$8.04 M

3-Year Low

-$33.64 M
PDSB annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PDSB previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 27, 2025
PDSB next annual earnings announcement is scheduled for Mar 27, 2025

OtherPDSBcash flowmetrics:

Annual CFI

-
PDSB annual cash flow from investing activities value is unknown

Annual CFF

$16.38 M
PDSB annual cash flow from financing activities is $16.38 million

Annual FCF

-$33.64 M
PDSB annual free cash flow is -$33.64 million

Annual CAPEX

-
PDSB annual capital expenditures value is unknown

Quarterly CFO

-$8.00 M
+$858.20 K+9.69%

September 30, 2024

Summary

Performance

3-Month Change

+9.69%

1-Year Change

+5.41%

3-Year Change

-66.16%

5-Year Change

-66.16%

PDSB Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.55%
PDSB quarterly cash flow from operations is higher than 35.55% of companies in Healthcare sector

High & Low

All-time High

$946.20 K
PDSB quarterly cash flow from operations is currently -945.46% below its historical high of $946.20 thousand

3-Year Low

-$13.19 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PDSB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
PDSB next earnings announcement is scheduled for Mar 27, 2025

OtherPDSBcash flowmetrics:

Quarterly CFI

$0.00
PDSB quarterly cash flow from investing activities is $0.00

Quarterly CFF

$17.20 K
PDSB quarterly cash flow from financing activities is $17.20 thousand

Quarterly FCF

-$8.00 M
PDSB quarterly free cash flow is -$8.00 million

Quarterly CAPEX

-
PDSB quarterly capital expenditures value is unknown

TTM CFO

-$35.25 M
-$823.80 K-2.39%

September 30, 2024

Summary

Performance

3-Month Change

-2.39%

1-Year Change

-4.81%

3-Year Change

-12.18%

5-Year Change

-12.18%

PDSB TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.41%
PDSB TTM cash flow from operations is higher than 34.41% of companies in Healthcare sector

High & Low

All-time High

-$4.26 M

3-Year Low

-$35.25 M
PDSB TTM cash flow from operations is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PDSB previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 27, 2025
PDSB next earnings announcement is scheduled for Mar 27, 2025

OtherPDSBcash flowmetrics:

TTM CFI

-$29.00 K
PDSB TTM cash flow from investing activities is -$29.00 thousand

TTM CFF

$30.78 M
PDSB TTM cash flow from financing activities is $30.78 million

TTM FCF

-$35.28 M
PDSB TTM free cash flow is -$35.28 million

TTM CAPEX

-
PDSB TTM capital expenditures value is unknown

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

PDSB Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-30.8%+5.4%-4.8%
3 y3 years-155.8%-66.2%-12.2%
5 y5 years-1.5%-66.2%-12.2%

PDSB Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-169.4%at low-77.7%+39.3%-182.3%at low
5 y5-year-169.4%at low-945.5%+39.3%-303.5%at low
alltimeall time-318.1%+17.4%-945.5%+74.9%-726.6%+20.7%

PDS Biotechnology Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$8.00 M(-9.7%)
-$35.25 M(+2.4%)
Jun 2024
-
-$8.86 M(-10.9%)
-$34.43 M(+13.3%)
Mar 2024
-
-$9.94 M(+17.5%)
-$30.39 M(-9.7%)
Dec 2023
-$33.64 M(+30.8%)
-$8.46 M(+17.9%)
-$33.64 M(+2.8%)
Sep 2023
-
-$7.18 M(+49.1%)
-$32.71 M(+4.1%)
Jun 2023
-
-$4.81 M(-63.5%)
-$31.42 M(-3.4%)
Mar 2023
-
-$13.19 M(+75.2%)
-$32.53 M(+26.5%)
Dec 2022
-$25.71 M(+105.9%)
-$7.53 M(+27.8%)
-$25.71 M(+13.3%)
Sep 2022
-
-$5.89 M(-0.4%)
-$22.68 M(+3.5%)
Jun 2022
-
-$5.92 M(-7.1%)
-$21.92 M(+45.6%)
Mar 2022
-
-$6.37 M(+41.5%)
-$15.05 M(+20.6%)
Dec 2021
-$12.49 M(-5.0%)
-$4.50 M(-12.2%)
-$12.49 M(-1.0%)
Sep 2021
-
-$5.13 M(-642.0%)
-$12.61 M(+44.4%)
Jun 2021
-
$946.20 K(-124.9%)
-$8.74 M(-36.6%)
Mar 2021
-
-$3.80 M(-17.9%)
-$13.79 M(+4.9%)
Dec 2020
-$13.15 M(-27.2%)
-$4.63 M(+269.7%)
-$13.15 M(-6.3%)
Sep 2020
-
-$1.25 M(-69.5%)
-$14.04 M(-18.0%)
Jun 2020
-
-$4.10 M(+29.7%)
-$17.12 M(-4.2%)
Mar 2020
-
-$3.16 M(-42.7%)
-$17.87 M(-1.1%)
Dec 2019
-$18.07 M
-$5.52 M(+27.6%)
-$18.07 M(-59.3%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$4.33 M(-10.9%)
-$44.45 M(+9.6%)
Jun 2019
-
-$4.86 M(+44.3%)
-$40.56 M(+12.3%)
Mar 2019
-
-$3.37 M(-89.4%)
-$36.12 M(+8.9%)
Dec 2018
-$33.15 M(-18.5%)
-$31.90 M(+7281.1%)
-$33.15 M(+216.0%)
Sep 2018
-
-$432.20 K(+4.0%)
-$10.49 M(-51.1%)
Jun 2018
-
-$415.40 K(+2.7%)
-$21.46 M(-29.2%)
Mar 2018
-
-$404.30 K(-95.6%)
-$30.33 M(-25.5%)
Dec 2017
-$40.70 M(+26.4%)
-$9.24 M(-18.9%)
-$40.70 M(+8.5%)
Sep 2017
-
-$11.40 M(+22.8%)
-$37.50 M(+7.5%)
Jun 2017
-
-$9.28 M(-13.8%)
-$34.90 M(+3.0%)
Mar 2017
-
-$10.77 M(+78.2%)
-$33.89 M(+5.3%)
Dec 2016
-$32.19 M(+48.0%)
-$6.05 M(-31.2%)
-$32.19 M(-2.2%)
Sep 2016
-
-$8.79 M(+6.3%)
-$32.93 M(+13.0%)
Jun 2016
-
-$8.28 M(-8.8%)
-$29.13 M(+9.7%)
Mar 2016
-
-$9.07 M(+33.8%)
-$26.56 M(+22.1%)
Dec 2015
-$21.75 M(+123.9%)
-$6.78 M(+35.7%)
-$21.75 M(+45.3%)
Sep 2015
-
-$5.00 M(-12.4%)
-$14.97 M(+50.1%)
Jun 2015
-
-$5.71 M(+33.8%)
-$9.97 M(+133.8%)
Mar 2015
-
-$4.26 M
-$4.26 M
Dec 2014
-$9.72 M(+20.8%)
-
-
Dec 2013
-$8.04 M
-
-

FAQ

  • What is PDS Biotechnology annual cash flow from operations?
  • What is the all time high annual CFO for PDS Biotechnology?
  • What is PDS Biotechnology annual CFO year-on-year change?
  • What is PDS Biotechnology quarterly cash flow from operations?
  • What is the all time high quarterly CFO for PDS Biotechnology?
  • What is PDS Biotechnology quarterly CFO year-on-year change?
  • What is PDS Biotechnology TTM cash flow from operations?
  • What is the all time high TTM CFO for PDS Biotechnology?
  • What is PDS Biotechnology TTM CFO year-on-year change?

What is PDS Biotechnology annual cash flow from operations?

The current annual CFO of PDSB is -$33.64 M

What is the all time high annual CFO for PDS Biotechnology?

PDS Biotechnology all-time high annual cash flow from operations is -$8.04 M

What is PDS Biotechnology annual CFO year-on-year change?

Over the past year, PDSB annual cash flow from operations has changed by -$7.93 M (-30.83%)

What is PDS Biotechnology quarterly cash flow from operations?

The current quarterly CFO of PDSB is -$8.00 M

What is the all time high quarterly CFO for PDS Biotechnology?

PDS Biotechnology all-time high quarterly cash flow from operations is $946.20 K

What is PDS Biotechnology quarterly CFO year-on-year change?

Over the past year, PDSB quarterly cash flow from operations has changed by +$457.50 K (+5.41%)

What is PDS Biotechnology TTM cash flow from operations?

The current TTM CFO of PDSB is -$35.25 M

What is the all time high TTM CFO for PDS Biotechnology?

PDS Biotechnology all-time high TTM cash flow from operations is -$4.26 M

What is PDS Biotechnology TTM CFO year-on-year change?

Over the past year, PDSB TTM cash flow from operations has changed by -$1.62 M (-4.81%)